Heron Therapeutics (HRTX) Prepaid Assets (2010 - 2026)
Heron Therapeutics' (HRTX) quarterly Prepaid Assets came in at $8.0 million in Q1 2026, down 69.93% YoY from $26.5 million in Q1 2025, and down 12.46% on a QoQ basis from $9.1 million in Q4 2025.
Heron Therapeutics (HRTX) Prepaid Assets (2010 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 17 years of Prepaid Assets data on file, last reported at $8.0 million in Q1 2026.
- Quarterly Prepaid Assets fell 69.93% year-over-year to $8.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.0 million (down 69.93% YoY) and the FY2025 annual result came in at $9.1 million, down 48.55% from the prior year.
- Prepaid Assets slipped to $8.0 million in Q1 2026, from $9.1 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $26.5 million in Q1 2025 to a low of $6.1 million in Q4 2023.
- A 5-year average of $12.5 million and a median of $10.8 million in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets plunged 72.4% — and 2025, when it soared 302.4%.
- Tracing HRTX's Prepaid Assets over 5 years: stood at $14.0 million in 2022, then slumped by 56.18% to $6.1 million in 2023, then surged by 189.15% to $17.7 million in 2024, then sank by 48.55% to $9.1 million in 2025, then fell by 12.46% to $8.0 million in 2026.
- The last three Prepaid Assets figures came in at $8.0 million (Q1 2026), $9.1 million (Q4 2025), and $22.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Heron Therapeutics | 59.96 Mn | 17.29 Mn | 26.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.03 Mn |
| Mar 31, 2026 | 7.97 Mn |
| Dec 31, 2025 | 9.10 Mn |
| Sep 30, 2025 | 22.84 Mn |
| Jun 30, 2025 | 17.39 Mn |
| Mar 31, 2025 | 26.49 Mn |
| Dec 31, 2024 | 17.69 Mn |
| Sep 30, 2024 | 11.31 Mn |
| Jun 30, 2024 | 7.25 Mn |
| Mar 31, 2024 | 6.58 Mn |
| Dec 31, 2023 | 6.12 Mn |
| Sep 30, 2023 | 10.77 Mn |
| Jun 30, 2023 | 10.72 Mn |
| Mar 31, 2023 | 14.63 Mn |
| Dec 31, 2022 | 13.96 Mn |
| Sep 30, 2022 | 7.63 Mn |
| Jun 30, 2022 | 9.05 Mn |
| Mar 31, 2022 | 13.11 Mn |
| Dec 31, 2021 | 12.96 Mn |
| Sep 30, 2021 | 27.64 Mn |